Konijnenberg MW - Search Results

1

Imaging DNA Damage Repair In Vivo After ¹⁷⁷Lu-DOTATATE Therapy.

O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. O'Neill E, et al. Among authors: konijnenberg mw. J Nucl Med. 2020 May;61(5):743-750. doi: 10.2967/jnumed.119.232934. Epub 2019 Nov 22. J Nucl Med. 2020. PMID: 31757844 Free PMC article.

2

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP. Kwekkeboom DJ, et al. Among authors: konijnenberg mw. Eur J Nucl Med. 2001 Sep;28(9):1319-25. doi: 10.1007/s002590100574. Eur J Nucl Med. 2001. PMID: 11585290

3

Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.

Capello A, Krenning EP, Breeman WA, Bernard BF, Konijnenberg MW, de Jong M. Capello A, et al. Among authors: konijnenberg mw. Cancer Biother Radiopharm. 2003 Oct;18(5):761-8. doi: 10.1089/108497803770418300. Cancer Biother Radiopharm. 2003. PMID: 14629824

4

A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.

Konijnenberg MW, Bijster M, Krenning EP, De Jong M. Konijnenberg MW, et al. J Nucl Med. 2004 Jul;45(7):1260-9. J Nucl Med. 2004. PMID: 15235075 Free article.

5

Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948.

Verwijnen S, Capello A, Bernard B, van den Aardweg G, Konijnenberg M, Breeman W, Krenning E, de Jong M. Verwijnen S, et al. Cancer Biother Radiopharm. 2004 Jun;19(3):285-92. doi: 10.1089/1084978041425098. Cancer Biother Radiopharm. 2004. PMID: 15285875

6

Radiolabelling DOTA-peptides with 68Ga.

Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP. Breeman WA, et al. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):478-85. doi: 10.1007/s00259-004-1702-y. Epub 2005 Jan 18. Eur J Nucl Med Mol Imaging. 2005. PMID: 15655678

7

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.

Konijnenberg M, Melis M, Valkema R, Krenning E, de Jong M. Konijnenberg M, et al. J Nucl Med. 2007 Jan;48(1):134-42. J Nucl Med. 2007. PMID: 17204710 Free article.

8

Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs.

Müller C, Forrer F, Bernard BF, Melis M, Konijnenberg M, Krenning EP, de Jong M. Müller C, et al. Cancer Biother Radiopharm. 2007 Feb;22(1):151-9. doi: 10.1089/cbr.2007.309. Cancer Biother Radiopharm. 2007. PMID: 17627424

9

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.

Forrer F, Krenning EP, Kooij PP, Bernard BF, Konijnenberg M, Bakker WH, Teunissen JJ, de Jong M, van Lom K, de Herder WW, Kwekkeboom DJ. Forrer F, et al. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1138-46. doi: 10.1007/s00259-009-1072-6. Epub 2009 Feb 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19247653 Free PMC article. Clinical Trial.

10

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.

Melis M, Bijster M, de Visser M, Konijnenberg MW, de Swart J, Rolleman EJ, Boerman OC, Krenning EP, de Jong M. Melis M, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1968-76. doi: 10.1007/s00259-009-1196-8. Eur J Nucl Med Mol Imaging. 2009. PMID: 19585115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page